Mechanistic Insights and Diagnostic Applications for Hypoxia-Induced Vasorin in Pancreatic Cancer
Mechanistic Insights and Diagnostic Applications for Hypoxia-Induced Vasorin in Pancreatic Cancer
批准号:
10088332
负责人:
Lisa Kirkemo
金额:
$4.11万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-01 至 2022-12-31
关键词:
AntibodiesAntigensApoptoticBacteriophagesBindingBinding ProteinsBiological AssayBiological MarkersBiotinylationCancer Cell GrowthCancer DiagnosticsCell LineCell ProliferationCell SurvivalCell surfaceCellsClassificationCleaved cellDataData SetDetectionDevelopmentDiagnosisDiagnosticDiseaseDisease modelEarly DiagnosisEarly InterventionEnvironmental Risk FactorEnzyme-Linked Immunosorbent AssayEpitopesEventExhibitsFab ImmunoglobulinsFibroblastsFutureGenesGlioblastomaGoalsGrowthHematologic NeoplasmsHumanHypoxiaImageImmuneImmunoPETImmunoprecipitationIn VitroLabelLinkMalignant NeoplasmsMalignant neoplasm of pancreasMass Spectrum AnalysisMembraneMetabolicMethodsModalityModelingMolecular TargetN-terminalNOTCH1 geneNU/NU MouseNeoplasm MetastasisNon-Invasive Cancer DetectionOxidative StressOxygenPancreasPathway interactionsPatientsPhage DisplayPhenotypePlayPositron-Emission TomographyPrimary NeoplasmProteinsProteolysisProteomeProteomicsPublishingRecombinant AntibodyRecombinant ProteinsRecombinantsRoleSerumSignal TransductionSiteSolidSolid NeoplasmStem Cell DevelopmentStreptavidinStressSurfaceTechnologyTestingTherapeuticTherapeutic InterventionTissuesToxic effectWestern BlottingZirconiumantibody diagnosticantibody engineeringbasecancer biomarkerscancer cellcancer immunotherapycancer stem cellcancer typecell growthclinically relevantdeprivationdesensitizationdesignexperienceexperimental studyglycoproteomicsin vivoin vivo Modelinsightknock-downmigrationmortalitymouse modelnovelnovel strategiespancreatic cancer cellspancreatic cancer modelpancreatic cancer patientspancreatic neoplasmprogramsprotective effectprotein expressionprotein protein interactionradiotracerresponsetooltranscriptomicstumortumor hypoxiatumor microenvironmentvirtual
中文摘要
项目摘要
随着癌症免疫疗法的出现,患者已经看到免疫疗法的可用性急剧增加。
各种恶性肿瘤的治疗选择。然而,这些方式中的许多在治疗实体瘤方面缺乏功效。
肿瘤,即因为这些肿瘤内存在的独特的环境因素。之一
肿瘤微环境(TME)中最普遍存在的特征是缺氧,也称为缺氧。
缺氧长期以来,低氧与患者转移增加和预后不良有关。响应
对于低氧应激,癌细胞激活高度调节的细胞通路和基因程序,
存活、迁移、免疫豁免和患者死亡率增加。在所有实体瘤中,胰腺
癌症表现出最严重的缺氧表型,这可能导致与癌症相关的高死亡率。
这种类型的癌症。这些缺氧特异性下游效应表明,肿瘤缺氧可用于
阐明用于诊断和治疗目的的实体胰腺癌的选择性生物标志物。在这里,我利用
细胞表面蛋白质组学,以确定一种新的缺氧调节靶点,在胰腺癌称为血管紧张素(Vasorin),
一个先前与胶质母细胞瘤进展有关的靶点。此外,我已经证明,
在缺氧应激下胰腺癌的生长和存活中起重要作用。最后,我分离出了
并表达了10个针对VEGFR2胞外域的独特抗体克隆。使用这些抗体,我发现,
VEGFR2在体外缺氧条件下经历了许多切割事件,这是以前发表的独特的
结果我们假设VEGFR2裂解对于胰腺癌的存活和增殖是必需的
以及相关肿瘤中切割特异性形式VEGF1表达水平分类
模型将有助于低氧胰腺癌基于抗体的诊断的下游开发。到
为了验证这一假设,我将采用蛋白质组学表征和重组蛋白表达来鉴定
在体外细胞的结果,维生素C蛋白水解。为了将克隆分离到膜保留的
对于切割的VEGFR3的形式,我将使用已建立的基于噬菌体展示的重组抗体策略。选择性
将实施基于抗体的生物素化策略来识别膜的新型相互作用伙伴-
保留形式的切割的VEGFR2,其可能在下游信号传导中起重要作用。最后要
功能化我现有的和未来的抗VEGFR2抗体克隆用于基于血清的ELISA检测,
分别进行基于放射性示踪剂的VEGF-C免疫PET成像,这将验证蛋白水解的存在。
在人血清和肿瘤中以及在胰腺癌的体内nu/nu小鼠模型中,的
拟议的研究将提供机械的见解,功能的后果,钒蛋白水解,
胰腺癌,以及提供证据的发展,非侵入性,早期发现诊断
高转移性致命疾病的替代品
英文摘要
Project Summary
With the advent of cancer immunotherapies, patients have seen dramatic increases in the availability of
treatment options for various malignancies. However, many of these modalities lack efficacy in treating solid
tumors, namely because of the unique set of environmental factors that exist within these tumors. One of the
most ubiquitous features within the tumor microenvironment (TME) is oxygen deprivation, also known as
hypoxia. Hypoxia has long been linked to increased metastasis and poorer prognoses for patients. In response
to hypoxic stress, cancer cells activate highly regulated cellular pathways and gene programs that promote
survival, migration, immune privilege, and increased mortality for patients. Across all solid tumors, pancreatic
cancer exhibits the most severe hypoxic phenotype, which may contribute to the high mortality rate associated
with this cancer type. These hypoxia-specific downstream effects suggest that tumor hypoxia can be used to
elucidate selective biomarkers of solid pancreatic cancer for diagnostic and therapeutic purposes. Here, I utilize
cell surface proteomics to identify a novel hypoxia-regulated target in pancreatic cancer called vasorin (VASN),
a target previously implicated in the progression of glioblastoma. Furthermore, I have shown that VASN plays
an important role in the growth and survival of pancreatic cancer under hypoxic stress. Finally, I have isolated
and expressed ten unique antibody clones against the ectodomain of VASN. Using these antibodies, I found that
VASN undergoes numerous cleavage events under hypoxia in vitro, which are unique from previously published
results. We hypothesize that VASN cleavage is necessary for the survival and proliferation of pancreatic cancer
under hypoxia, and that classification of expression levels for cleavage-specific forms of VASN in relevant tumor
models will aid the downstream development of antibody-based diagnostics for hypoxic pancreatic cancer. To
test this hypothesis, I will employ proteomic characterization and recombinant protein expression to identify the
in vitro cellular consequences of VASN proteolysis. In order to isolate clones towards the membrane-retained
form of cleaved VASN, I will use an established phage display-based recombinant antibody strategy. A selective
antibody-based biotinylation strategy will be implemented to identify novel interacting partners of the membrane-
retained form of cleaved VASN that may play an important role in downstream signaling. Finally, I will
functionalize my existing and future anti-VASN antibody clones for serum-based ELISA detection and
radiotracer-based immunoPET imaging of VASN, respectively, which will validate the presence of proteolyzed
VASN in human serum and tumors, as well as in an in vivo nu/nu mouse model of pancreatic cancer. The
proposed studies will provide mechanistic insights into the functional consequences of VASN proteolysis in
pancreatic cancer, as well as providing evidence for the development of non-invasive, early-detection diagnostic
alternatives for a highly metastatic and deadly disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic Insights and Diagnostic Applications for Hypoxia-Induced Vasorin in Pancreatic Cancer
-
批准号:9911865
-
项目类别:
-
资助金额:$4.06万
-
财政年份:2020
-
负责人:Lisa Kirkemo
-
依托单位:
Mechanistic Insights and Diagnostic Applications for Hypoxia-Induced Vasorin in Pancreatic Cancer
-
批准号:10319591
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2020
-
负责人:Lisa Kirkemo
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: